Trials / Completed
CompletedNCT06213740
Validation of a New Simplified Scoring System for Acute Calculous Cholecystitis
Validation of a New Simplified Scoring System (ACME) for Acute Calculous Cholecystitis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 387 (actual)
- Sponsor
- Hospital del Mar · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is surgical treatment (ST) and the accepted mortality is \<1%, but in severe and/or fragile patients is higher. Despite the Tokyo Guidelines, there no consensus on who is the unfit patient for ST. A recent study has identified 4 risk factors that predicts the mortality in a 92% of patients (ACME) and could help to develop new guidelines in ACC. The aim of this study is this validation of the new simplified scoring system for mortality in ACC.
Detailed description
This is a retrospective single-center observational study of 387 adults with ACC during 2 non-consecutive years (2017/2021), including baseline demographic characteristics, comorbidity severity defined as Charlson Comorbidity Index (CCI), ASA Score, Tokyo Guidelines' severity classification and the new ACME Score. The primary outcome is to study the prediction of mortality of ACME score. Secondary outcomes include complications following Clavien-Dindo's classification, C-statistic, and ROC Curves.
Conditions
Timeline
- Start date
- 2021-01-08
- Primary completion
- 2021-05-01
- Completion
- 2021-12-17
- First posted
- 2024-01-19
- Last updated
- 2024-01-23
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06213740. Inclusion in this directory is not an endorsement.